Here is a comprehensive overview of Tetralogy of Fallot (ToF).
Tetralogy of Fallot
Definition & Epidemiology
Tetralogy of Fallot is the most common cyanotic congenital heart disease, accounting for ~5% of all congenital cardiac malformations, with an incidence of approximately 420 per million live births.
The Four Cardinal Defects
All four features arise from a single embryologic defect: anterosuperior displacement of the infundibular (outlet) septum, causing unequal division of the truncus arteriosus.
| # | Defect | Details |
|---|
| 1 | Right Ventricular Outflow Tract (RVOT) Obstruction | Usually subpulmonic (infundibular) stenosis; may be valvular stenosis or complete pulmonary atresia |
| 2 | Large, Unrestrictive VSD | Near the membranous septum; allows bidirectional shunting |
| 3 | Overriding Aorta | Aortic valve straddles the VSD, receiving blood from both ventricles |
| 4 | Right Ventricular Hypertrophy | Secondary to high pressure load from RVOT obstruction |
Classic ToF: right-to-left shunting across the VSD. Ao = Aorta, PT = Pulmonary Trunk, RA/RV/LA/LV = cardiac chambers. (Robbins & Kumar Basic Pathology)
Pathophysiology
The physiologic result is decreased pulmonary blood flow + right-to-left shunting of deoxygenated blood across the VSD into the aorta.
Hemodynamics of ToF: severity of shunt depends on degree of RVOT obstruction, VSD size, and systemic vascular resistance (SVR). (Rosen's Emergency Medicine)
- Severity is proportional to the degree of RVOT obstruction
- Mild obstruction → left-to-right shunt only → "Pink Tet" (acyanotic)
- Severe obstruction → early profound cyanosis
- In pulmonary atresia: pulmonary flow entirely via PDA or bronchial collaterals
Morphology
- Boot-shaped heart (coeur en sabot) — from RV hypertrophy elevating the cardiac apex
- Proximal aorta dilated; pulmonary trunk hypoplastic
- RV wall markedly hypertrophied (may exceed LV thickness)
- Left-sided chambers are normal in size
Clinical Features
| Feature | Details |
|---|
| Cyanosis | Worsens with crying, feeding, exertion; may be absent at birth |
| Systolic ejection murmur | Left sternal border (from RVOT obstruction, NOT the VSD) |
| Clubbing | Fingers and toes; from chronic hypoxemia |
| Polycythemia | Compensatory response to chronic hypoxia |
| Squatting | Older children squat to increase SVR and reduce R→L shunt |
| Chest X-ray | Boot-shaped heart, decreased pulmonary vascular markings, possible right-sided aortic arch (~25%) |
| ECG | RV hypertrophy, right axis deviation |
Tet Spells (Hypercyanotic/Hypoxic Spells)
Peak incidence: 2–4 months of age
Trigger: Anything that suddenly ↓SVR (crying, defecation, fever) or causes tachycardia/hypovolemia
Vicious cycle:
↓SVR → ↑R→L shunt → ↓PaO₂, ↑PCO₂, ↓pH → hyperpnea → ↑venous return to RV → more shunting → worsening hypoxia
Clinical signs: Hyperpnea, prolonged crying, deepening cyanosis, decreased murmur intensity, possible limpness, seizures, stroke, or death.
Management of Tet Spells (Rosen's Box 165.8)
- Knee-to-chest position (or squatting) — increases SVR, reduces R→L shunt
- Supplemental oxygen (limited effect alone)
- Morphine 0.1–0.2 mg/kg IV/IM (sedation, ↓catecholamines) — note risk of histamine-mediated vasodilation
- Fentanyl 1 µg/kg IV/IM or 1.5–2 µg/kg intranasal (preferred over morphine)
- Midazolam 0.2–0.3 mg/kg intranasal
- Ketamine 1–2 mg/kg IV or 3–5 mg/kg IM — excellent (↑SVR + sedation)
- NaHCO₃ 1 mEq/kg IV — if metabolic acidosis (pH <7.4)
- Phenylephrine 0.01–0.02 mg/kg IV — α-agonist to ↑SVR
- Propranolol 0.1–0.2 mg/kg IV — may reduce infundibular spasm
- IV fluids — to ↑preload and pulmonary flow
Associated Defects
- Right-sided aortic arch (~25%)
- ASD
- Anomalous coronary artery origin (left coronary from right coronary artery in ~5% — critical surgical relevance)
- Pulmonary atresia with VSD = extreme form of ToF
Surgical Management
Palliative (staged)
- Modified Blalock-Taussig (BT) shunt: subclavian artery → ipsilateral pulmonary artery anastomosis
- Used when: severe cyanosis, very narrow RVOT, hypoplastic central pulmonary arteries
Definitive Repair
- VSD closure + RVOT relief (infundibular resection ± transannular patch across pulmonary valve annulus)
- Preferred: early single-stage repair in infancy
- Surgical mortality: ~5–10% in uncomplicated cases within first 2 years
- PGE₁ (prostaglandin E₁) infusion may be needed pre-operatively to maintain PDA patency in severely cyanotic neonates
Post-repair Residua (almost universal)
- Pulmonary regurgitation (PR) — most common long-term problem
- RV dilatation, RVOT aneurysm
- Residual RVOT obstruction or VSD
- Aortic root dilatation
- Right bundle branch block (from right ventriculotomy)
- Complete heart block, ventricular arrhythmias
- CMR is gold standard for RV assessment post-repair; guides timing of pulmonary valve replacement
Pulmonary Valve Replacement
- Surgical redo vs. transcatheter pulmonary valve replacement (TPVR) — both are options; recent 2025 systematic review (PMID 40122137) compared outcomes
- Timing of intervention guided by RV volumes/function on CMR
Recent Evidence
- Primary vs. staged repair in symptomatic neonates (Meta-analysis, Cardiol Young 2024; PMID 39444206): systematic review comparing outcomes of primary vs. staged surgical approach in symptomatic neonates.
- Surgical vs. transcatheter pulmonary valve redo (Expert Rev Cardiovasc Ther 2025; PMID 40122137): systematic review of redo pulmonary valve options in repaired ToF patients.
Sources: Robbins & Kumar Basic Pathology | Rosen's Emergency Medicine | Grainger & Allison's Diagnostic Radiology | The Developing Human (Moore) | Braunwald's Heart Disease